Vimarsana
Biggest News Aggregation in the World

Worst Itch News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Worst Itch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Worst Itch Today - Breaking & Trending Today

Roflumilast Cream Safe, Effective for Kids With Psoriasis - Vimarsana News

Roflumilast Cream Safe, Effective for Kids With Psoriasis

"Limited topical treatments are approved for children younger than 12 years old with psoriasis."

Difelikefalin Helps Upper Back Itch, but With Side Effects - Vimarsana News

Difelikefalin Helps Upper Back Itch, but With Side Effects

Phase 2 results show a reduction in itch in patients with notalgia paresthetica, but 19% of patients discontinued the trial because of side effects compared with 6% in the placebo group.

Arcutis Announces Positive Topline Results from ARRECTOR Pivotal Phase 3 Trial of Roflumilast Foam 0.3% in Scalp and Body Psoriasis - Vimarsana News

Arcutis Announces Positive Topline Results from ARRECTOR Pivotal Phase 3 Trial of Roflumilast Foam 0.3% in Scalp and Body Psoriasis

26.09.2022 - Study met both co-primary endpoints and all secondary endpointsAt week eight, 67.3% of individuals treated with roflumilast foam achieved Scalp-Investigator Global Assessment (S-IGA) Success compared to 28.1% of individuals treated with vehicleAt ... Seite 1

New 30 Patient Study Of AOBiome's New Shelf-Stable Formulation Of Its Ammonia Oxidizing Bacteria (AOB) Shows Reduction Of Itch Levels In Both Pediatric And Adult Subjects Who Suffer From Eczema. - Vimarsana News

New 30 Patient Study Of AOBiome's New Shelf-Stable Formulation Of Its Ammonia Oxidizing Bacteria (AOB) Shows Reduction Of Itch Levels In Both Pediatric And Adult Subjects Who Suffer From Eczema.

/PRNewswire/ -- AOBiome Therapeutics, Inc. ("AOBiome"), a leading clinical-stage microbiome company focusing on inflammatory conditions, has announced the...